BERUZATATUG PELITECAN
UNII DAW7F54AQE

Substance Identification & Data

This profile provides standardized clinical and technical data for Beruzatatug Pelitecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DAW7F54AQE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2948329-91-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DAW7F54AQE

CAS Registry Number

2948329-91-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BERUZATATUG PELITECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13926

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Beruzatatug Pelitecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BERUZATATUG PELITECAN

Common Names & Synonyms

BERUZATATUG PELITECAN [INN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER3) (HUMAN MONOCLONAL YL202 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN MONOCLONAL YL202 .KAPPA.-CHAIN, DIMER, OCTAKIS(THIOETHER) WITH N-(6-(2-MERCAPTO-5-PYRIMIDINYL)-1-OXO-5-HEXYN-1-YL)-L-VALYL-N6,N6-DIPROPYL-L-LYSYL-N-((3-((7S)-7-ETHYL-7,8,11,13-TETRAHYDRO-7-HYDROXY-8,11-DIOXO-10H-1,3-DIOXOLO(4,5-G)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-14-YL)PROPOXY)METHYL)GLYCINAMIDE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSIN-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF EIGHT CYSTEINYL RESIDUES TO PELITECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (BERUZATATUG PELITECAN)

External Clinical & Regulatory Resources

Previous UNIIDAV805YGOX

Next UNIIDAX5W38Z2X